145 related articles for article (PubMed ID: 30655721)
1. Human chorionic gonadotropin value and its change prior to methotrexate treatment can predict the prognosis in ectopic tubal pregnancies.
Watanabe K; Chigusa Y; Kondoh E; Mogami H; Horie A; Baba T; Mandai M
Reprod Med Biol; 2019 Jan; 18(1):51-56. PubMed ID: 30655721
[TBL] [Abstract][Full Text] [Related]
2. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.
Goh A; Karine P; Kirby A; Williams C; Kapurubandara S
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399
[TBL] [Abstract][Full Text] [Related]
3. Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy.
Zhang J; Zhang Y; Gan L; Liu XY; Du SP
BMC Pregnancy Childbirth; 2020 Oct; 20(1):654. PubMed ID: 33121473
[TBL] [Abstract][Full Text] [Related]
4. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
[TBL] [Abstract][Full Text] [Related]
5. Early (Days 1-4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy.
Mackenzie SC; Moakes CA; Doust AM; Mol BW; Duncan WC; Tong S; Horne AW; Whitaker LHR
Hum Reprod; 2023 Jul; 38(7):1261-1267. PubMed ID: 37178269
[TBL] [Abstract][Full Text] [Related]
6. Early prediction of methotrexate treatment outcome in tubal ectopic pregnancy based on days 0 and 4 human chorionic gonadotropin levels.
Shatkin Hamish N; Wolf M; Tendler R; Sharon A; Bornstein J; Odeh M
J Obstet Gynaecol Res; 2020 Jul; 46(7):1104-1109. PubMed ID: 32406562
[TBL] [Abstract][Full Text] [Related]
7. The importance of β-hCG values in prediction of the effectiveness of single dose methotrexate therapy in tubal ectopic pregnancy.
Yıldız A; Bilge O
Ginekol Pol; 2023; 94(4):303-308. PubMed ID: 35315015
[TBL] [Abstract][Full Text] [Related]
8. Early prediction of the failure of methotrexate treatment by Days 1-4 serum β-hCG change and 48-hour pre-treatment increment inβ-hCG.
Zhou H
J Obstet Gynaecol; 2023 Dec; 43(1):2183824. PubMed ID: 36862104
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the parameters in predicting single-dose methotrexate therapy success for ectopic pregnancy.
Deniz S; Ali B; Canan U; Yılmaz AH; Olcay I; Burcu D; Fatma GK
J Obstet Gynaecol Res; 2024 May; 50(5):856-863. PubMed ID: 38476034
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Successful Medical Management With Methotrexate in Unruptured Tubal Ectopic Pregnancy.
Ray A; Gaur A; Kumari S
Cureus; 2022 Nov; 14(11):e31923. PubMed ID: 36580082
[TBL] [Abstract][Full Text] [Related]
11. Daily variations and levels of human chorionic gonadotropin before methotrexate treatment as predictors of treatment success.
Yu Y; Li Y; Yang X; Fan Q; Cao D; Wang Y
J Obstet Gynaecol Res; 2022 Dec; 48(12):3128-3136. PubMed ID: 36056536
[TBL] [Abstract][Full Text] [Related]
12. Multidose Methotrexate Treatment of Ectopic Pregnancies with High initial β-Human Chorionic Gonadotropin: Can Success Be Predicted?
Tug N; Sargin MA; Yassa M
Gynecol Obstet Invest; 2019; 84(1):56-63. PubMed ID: 30099453
[TBL] [Abstract][Full Text] [Related]
13. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
[TBL] [Abstract][Full Text] [Related]
14. Ruptured ectopic pregnancies following methotrexate treatment: clinical course and predictors for improving patient counseling.
Cohen A; Bar-On S; Cohen Y; Sandel O; Fouks Y; Michaan N; Tzur T; Levin I
Reprod Sci; 2022 Apr; 29(4):1209-1214. PubMed ID: 35157263
[TBL] [Abstract][Full Text] [Related]
15. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?
Gabbur N; Sherer DM; Hellmann M; Abdelmalek E; Phillip P; Abulafia O
Am J Perinatol; 2006 Apr; 23(3):193-6. PubMed ID: 16586235
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment.
Hutchinson AP; Pereira N; Chung ER; Shah NJ; Zeku M; Chung PH; Rosenwaks Z
Gynecol Endocrinol; 2019 Jan; 35(1):49-52. PubMed ID: 30322280
[TBL] [Abstract][Full Text] [Related]
17. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
[TBL] [Abstract][Full Text] [Related]
18. The role of early determination of β-human chorionic gonadotropin levels in predicting the success of single-dose methotrexate treatment in ectopic pregnancy.
Çelik H; Tosun M; Işık Y; Avcı B
Ginekol Pol; 2016; 87(7):484-7. PubMed ID: 27504939
[TBL] [Abstract][Full Text] [Related]
19. Trends in serum human chorionic gonadotropin levels 0-4 days after methotrexate administration for predicting tubal ectopic pregnancy treatment success.
Wong L; Fung LWY; Cheung CW; Lao TT
Int J Gynaecol Obstet; 2018 May; 141(2):245-249. PubMed ID: 29214643
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis.
Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D
Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
